Ayad K. Ali

Eli Lilly and Company

Presentation(s):

• SP04F - Effectiveness of Direct Healthcare Professional Communication for Concentrated Insulin Lispro (U-200 Kwikpen) in France, Germany, and Sweden

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• SP16D - Burden of Comorbidities Among Adults with Concurrent Obesity and Heart Failure with Preserved Ejection Fraction

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time

• SP16H - Incidence and Prevalence of Rhabdomyolysis in Patients with Type 2 Diabetes in the US

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time